Skip to Content

251 (Pramipexole Dihydrochloride Extended-Release 0.375 mg)

Pill with imprint 251 is White, Round and has been identified as Pramipexole Dihydrochloride Extended-Release 0.375 mg. It is supplied by Par Pharmaceutical Inc.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.375 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 251

Pramipexole Dihydrochloride Extended-Release

Imprint
251
Strength
0.375 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Inc
National Drug Code (NDC)
10370-0251

Get help with Imprint Code FAQs.

Related Images for "251"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.